Back
Intellia Therapeutics Vs. Pacific Biosciences of California Industry Stock Comparison
Sell
45
NTLA
Intellia Therapeutics
Last Price:
25.88
Seasonality Move:
33.25%
Buy
55
PACB
Pacific Biosciences of California
Last Price:
1.93
Seasonality Move:
10.82%
Sell
45
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $26.22. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Pacific Biosciences of California (PACB)
is a Buy
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $2.02. The Score for PACB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PACB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $26.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight buying pressure.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 62.46 | Buy |
Chaikin Money Flow: | 117641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.24 - 24.92) | Buy |
Bollinger Bands (100): | (23.55 - 29.45) | Sell |
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 45.88 | Sell |
Chaikin Money Flow: | -6407106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.42 - 2.1) | Buy |
Bollinger Bands (100): | (2.34 - 7.18) | Sell |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.26 | Buy |
20-day SMA: | 23.39 | Buy |
50-day SMA: | 24.93 | Buy |
200-day SMA: | 29.22 | Sell |
8-day EMA: | 25.36 | Buy |
20-day EMA: | 24.39 | Buy |
50-day EMA: | 24.9 | Buy |
200-day EMA: | 29.74 | Sell |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.96 | Buy |
20-day SMA: | 1.77 | Buy |
50-day SMA: | 2.72 | Sell |
200-day SMA: | 6.9 | Sell |
8-day EMA: | 2.01 | Buy |
20-day EMA: | 2.02 | Sell |
50-day EMA: | 2.85 | Sell |
200-day EMA: | 6.17 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.26 per share, and a decrease next year of $0.19 per share.
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.17 per share.
Intellia Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pacific Biosciences of California Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |